Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada flag Canada · Delayed Price · Currency is CAD
0.6700
-0.0100 (-1.47%)
Oct 22, 2025, 10:49 AM EDT

Thiogenesis Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
33283323--
Market Cap Growth
-7.70%-17.40%48.30%---
Enterprise Value
31233021--
Last Close Price
0.640.600.750.58--
PB Ratio
72.628.066.053.77--
P/TBV Ratio
72.628.066.053.77--
Debt / Equity Ratio
-----0.43-1.04
Quick Ratio
1.277.064.1820.360.180.06
Current Ratio
1.317.144.2320.480.180.15
Return on Equity (ROE)
-195.45%-70.25%-87.95%-159.48%--
Return on Assets (ROA)
-93.94%-39.85%-48.08%-38.51%-738.68%-
Return on Capital (ROIC)
-126.23%-49.96%-56.52%-46.65%--
Earnings Yield
-15.36%-11.39%-15.15%-17.41%--
Buyback Yield / Dilution
-8.65%-15.93%-54.71%-118.86%-15.56%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.